VIDEO CHAT

CRISPR's forward march

Wednesday, Aug. 5, at 1 p.m. ET / 10 a.m. PT
 
Scientists are developing improved forms of genome editing, increasing the number of inherited diseases the technology may one day treat. Research veterans have a warning: be prepared for surprises.
 
Speakers include:
  • Sponsor Introduction: Robert Deans, Ph.D., chief scientific officer, Synthego
  • David R. Liu, Richard Merkin Professor and vice-chair of the faculty, Broad Institute; Investigator, Howard Hughes Medical Institute; Thomas Dudley Cabot Professor of the Natural Sciences and professor of chemistry & chemical biology, Harvard University
  • Alexis A. Thomspon, M.D., M.P.H., Sarah and A. Watson Armour Chair in childhood cancer and blood disorders, hematology section head, Ann & Robert H. Lurie Children’s Hospital of Chicago; professor of pediatrics, Feinberg School of Medicine, Northwestern University
  • STAT Moderator: Gideon Gil, managing editor, STAT

Sponsored by:synthego-logo-black